FDA DEVICE FACTS
HALYARD* PURPLE NITRILE – XTRA* Powder-Free Exam Gloves
Halyard Health
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
HALYARD* PURPLE NITRILE - XTRA* Powder Free Exam Gloves tested for Use with Chemotherapy Drugs are powder-free patient examination gloves that are a disposable device intended for medical purposes worn on the examiner's hand or finger to prevent contamination between patient and examiner. This is an over the counter medical device. The HALYARD* PURPLE NITRILE - XTRA* Powder Pree Exam Gloves have been tested with the following Chemotherapy drugs showing no breakthrough up to 240 minutes. Carmustine showed breakthrough at 80.4 minutes I-I Break-through Tie.. (rial Break-through Time (mins) Break-through Time (mins) ChemoTherapy ChemoTherapy Drug (com.) ChemoTherapy Drug (cone)Drug (conc.) > 240 >240Doxorubicin HCIArsenic Trioxide, Paraplatin>240(1 mqimil (2 mglrmp( EllenceAzacitidine (Vidaza) Pemnetrexed P25 mab i Pertuzurnab (20 mu/mI) > 240 >240 '240 > 240 > 240 (25 mgfrn]) 2mo/nil) I- > 240Bendamustine Eribulin Mesylate (05MQ/l) > 240 > 240Bleomycin sulfate Etoposid Raltitrexed (0.5 mgl)>240(15 mg/ml_ (20 mgmn_) Bortezomib (Velcade) Fludarabine Retrovir Rituximab > 240 > 240 > 240 > 240 (1 mgfml) 125 uig/rrl) I- > 240 Fulvestrant (5o mq/mi) Busulfan > 240 > 240 > 240Fluorouracil (50 mg/mi) Carfilzomib (2 mg/ml) Carbopalin (10 mp/imi) Temsirclimus (25 mp/mi) > 240 > 240 enmcitabine ThioTEPA Topotean H1 (1 mIml) >240 '240 > 240110.4 IdarubicinCarmustine (3.3 mqlml) > 240 > 240 >240Cetuximab (Erbitux) ifosfamide Trastuzumab> 240 Cisplatin (1 mg/tell > 2;40_I Irnotecan f20 mg/trll Triclosan (1mg/mi) Trisenox
- 10.1giml > 240 '240 > 240 > 240 > 240I- > 240Cyclophosphamide (20 mp/lml) Mechlorethamine HCI (I mg/mit) I- > 240 >240Cytarabine HCI (100 mplm) Melphalan Vinblastine (1 mqimrl) > 240 > 240 jJ Cytovene 10a ml il)_ Methatrexate Vincrinstine Sulfate (1 mp/ml)> 240 (25 mg/i) Mitomycin (.5 mg/mlL ' 240Dacarbazine Vinorelbine (10 mSm0) >240 > 240il-9 rnghmi) Hel > 240 > 240Daunorublcin Mitoxantrone Zoledronic Acid > 240L5 m/ml) _2 rngrmi) (0.8 mgmll > 240Decitabine Oxaliplalin >240(2mg/mi) ((- fr, m) '40 L -I Pacitaxel > 240(6 1/I
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。